Pilot study of antibiotic cycling in a pediatric intensive care unit

Crit Care Med. 2002 Aug;30(8):1877-82. doi: 10.1097/00003246-200208000-00034.

Abstract

Objective: This pilot study was performed to determine the safety and size of effect of antibiotic cycling to reduce colonization and infection with antibiotic-resistant bacteria.

Design: Open, observational study.

Setting: The study was performed in a 16-bed pediatric medical-surgical intensive care unit.

Patients: Critically ill children requiring antibiotic therapy.

Interventions: Three antibiotic classes were systematically cycled for 3-month intervals over 18 months. Antibiotic regimens were used for all empirical therapy and continued if the bacterial isolate was susceptible.

Measurements: The primary outcome was colonization with antibiotic-resistant bacteria, determined by surveillance cultures obtained twice monthly from all patients in the unit. Rates of antibiotic-resistant, nosocomial blood stream infections, and risks of colonization over calendar time in the intensive care unit were also evaluated.

Main results: The cycling of broad-spectrum, empirical antibiotics was safe and did not generate increased antibiotic resistance nor select for new organisms. Over the study period, the trend in prevalence of children colonized with antibiotic-resistant bacteria was from 29% to 24% (p =.41). The effect on prevalence of resistant blood stream infections was similar (p =.29). Changes in individual risks of colonization with resistant bacteria over calendar time were consistent with the ecologic effect in size and direction.

Conclusions: Results of this pilot intervention suggest that cycling antibiotics may be a safe and viable strategy to minimize the emergence of antibiotic resistance in intensive care units. A definitive study will require a randomized and controlled trial of only four pediatric intensive care units over an 18-month period.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / immunology*
  • Anti-Bacterial Agents / therapeutic use*
  • Baltimore / epidemiology
  • Child
  • Child Welfare
  • Drug Resistance / immunology
  • Endpoint Determination
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / epidemiology
  • Gram-Negative Bacterial Infections / immunology
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / immunology
  • Humans
  • Intensive Care Units, Pediatric*
  • Patient Admission
  • Patient Compliance
  • Patient Readmission
  • Pilot Projects
  • Prevalence
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents